Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
fda
4
×
indiana blog main
4
×
indiana top stories
life sciences
national blog main
boston blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
national
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
biogen
boston top stories
calcitonin gene-related peptide
cancer
chronic migraine
deerfield management
eli lilly
episodic migraine
europe blog main
europe top stories
What
medicines
4
×
fda
new
announced
approval
bio
class
covid
developed
drug
ipo
migraine
pain
roundup
starts
won
acquisitions
activity
amgen
approvals
approved
biogen
candidates
ceo
clamped
collabs
daniel
deal
decision
delays
developing
economic
eli
fast
gets
gilead
gilead’s
head
headache
help
Language
unset
Current search:
fda
×
" indiana blog main "
×
medicines
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines